Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
St. Jude Children's Research Hospital
Novartis
Hackensack Meridian Health
National Cancer Institute (NCI)
Novartis
Takeda
Gamida Cell ltd
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Novartis
Thomas Jefferson University
Baylor College of Medicine
Novartis
Novartis
OHSU Knight Cancer Institute
Stanford University
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
American Regent, Inc.
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
M.D. Anderson Cancer Center
Novartis
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Stanford University
Kyowa Kirin Co., Ltd.
Medical College of Wisconsin
Fred Hutchinson Cancer Center
Northwestern University
Novartis
M.D. Anderson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
Washington University School of Medicine
Pfizer
University of Nebraska
M.D. Anderson Cancer Center
Pfizer
University of Nebraska
National Institutes of Health Clinical Center (CC)
Center for International Blood and Marrow Transplant Research